Literature DB >> 11279081

Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human gamma delta T cells.

E Espinosa1, C Belmant, F Pont, B Luciani, R Poupot, F Romagné, H Brailly, M Bonneville, J J Fournié.   

Abstract

Small phosphorylated metabolites from mycobacteria stimulate human gammadelta T lymphocytes. Although such phosphoantigens could prove useful in the composition of vaccines involving gammadelta T cell-mediated immunity, their very low abundance in natural sources limits such applications. Here, we describe the chemical production, purification, and bioactivity of a phosphorylated bromohydrin (BrHPP) analogue that mimics the biological properties of natural phosphoantigens. This compound can be obtained in gram amounts, is easy to detect, and is of high stability in aqueous solutions. Whereas unspecific binding of BrHPP to a wide panel of cell surface receptors is not detected even at micromolar concentrations, nanomolar concentrations specifically trigger effector responses of human gammadelta T lymphocytes. Thus, BrHPP is a novel molecule enabling potent immunostimulation of human gammadelta T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279081     DOI: 10.1074/jbc.M100495200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Expansion of human peripheral blood γδ T cells using zoledronate.

Authors:  Makoto Kondo; Takamichi Izumi; Nao Fujieda; Atsushi Kondo; Takeharu Morishita; Hirokazu Matsushita; Kazuhiro Kakimi
Journal:  J Vis Exp       Date:  2011-09-09       Impact factor: 1.355

2.  γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody.

Authors:  Mounia Sabrina Braza; Bernard Klein; Geneviève Fiol; Jean-François Rossi
Journal:  Haematologica       Date:  2010-11-25       Impact factor: 9.941

Review 3.  Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.

Authors:  Hamid Reza Mirzaei; Hamed Mirzaei; Sang Yun Lee; Jamshid Hadjati; Brian G Till
Journal:  Cancer Lett       Date:  2016-07-05       Impact factor: 8.679

4.  Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity.

Authors:  Charles T Spencer; Getahun Abate; Azra Blazevic; Daniel F Hoft
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 5.  Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

Authors:  Barbara Castella; Candida Vitale; Marta Coscia; Massimo Massaia
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

Review 6.  Human gamma delta T cells: Evolution and ligand recognition.

Authors:  Erin J Adams; Siyi Gu; Adrienne M Luoma
Journal:  Cell Immunol       Date:  2015-05-06       Impact factor: 4.868

7.  Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes.

Authors:  Gabriele Pizzolato; Hannah Kaminski; Marie Tosolini; Don-Marc Franchini; Fréderic Pont; Fréderic Martins; Carine Valle; Delphine Labourdette; Sarah Cadot; Anne Quillet-Mary; Mary Poupot; Camille Laurent; Loic Ysebaert; Serena Meraviglia; Francesco Dieli; Pierre Merville; Pierre Milpied; Julie Déchanet-Merville; Jean-Jacques Fournié
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-22       Impact factor: 11.205

8.  Human Vδ2 T cells are a major source of interleukin-9.

Authors:  Christian Peters; Robert Häsler; Daniela Wesch; Dieter Kabelitz
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

Review 9.  Structure-Activity Relationships of Butyrophilin 3 Ligands.

Authors:  Andrew J Wiemer
Journal:  ChemMedChem       Date:  2020-05-26       Impact factor: 3.466

10.  A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils.

Authors:  Fanny Legrand; Virginie Driss; Gaëtane Woerly; Sylvie Loiseau; Emmanuel Hermann; Jean-Jacques Fournié; Laurent Héliot; Virginie Mattot; Fabrice Soncin; Marie-Lise Gougeon; David Dombrowicz; Monique Capron
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.